Sultan_of_Ping wrote: » Even Dyson - a company to be admired in many respects, even if the politics of the man himself are repugnant - struggled with developing their CoVent, and are having to take it through prototyping and assessment - which will take months, even for them with all their background in innovation and "air" handling. I'd also bet that even they will hit significant potholes on the way and even after it has been deployed.
Ballso wrote: » What do you know about research? You an expert on scientific and clinical research too now? Hint: you aren't. You aren't an expert on anything.
tikkahunter wrote: » Exactly. McClaren threw their hat at the ventilators and found it too complex to make so started manufacturing a valve that’s needed for the inflated hoods . Producing a product that compiles with regulations to a certain standard takes a long time to achieve and companies are doing their best .
FrancieBrady wrote: » AGAIN Sultan...nobody was talking about the level of difficulties or challenges here. What was dismissed was a call to them to 'step up to the plate'. As we now know some of them are indeed stepping up.
Sultan_of_Ping wrote: » Ok, and what in your opinion are the difficulties and logistics issues and how will they be overcome? Don't stop now - you felt secure enough to say the pharma sector could "step-up" - so how can they step-up (reagent production aside) and what are the constraining factors or barriers stopping them from stepping up and/or taking a bigger step up? I'm only asking because I work in the medical device area and I'm hoping for some ideas I can pass off as my own Should we swap over (step up) to doing Covid-19 work or just beetle away with what we're doing?
joeguevara wrote: » Which Irish journalists? Where did you see that they are planning to investigate it?
Runaways wrote: » There are at least three Irish journalists of note have picked up on it and two planning to investigate it. But yeah. We’re all imagining it. Try harder.
The pretext of the suspicion is ludicrous: Fine Gael have invested money in bot Twitter accounts capable of generating grammatically correct and contextually sensible messages of support, but can only generate cookie cutter Twitter handles, can’t add profile pictures and aren’t capable of following each other. Not only that, but Fine Gael ramped up their efforts to do so after a general election and during a global pandemic (apparently in case people deviate to team coronavirus).
Runaways wrote: » Provo defeat? Struggle? Are you talking to us from the early 80s or something?
Mortelaro wrote: » Are you looking for a job with Donald Trump What companies that should be are not 'stepping up to the plate' as you say We'll park your insistence that some were saying it was impossible for now Just deal with that point Name them
Runaways wrote: » If anyone was ever in any doubt if the existence of paid accounts online...............
Augeo wrote: » "..... some of them are indeed stepping up" ............ that suggests that some could but aren't for whatever reason ......... a total ignorance and lack of understanding of the pharma industry and the regulated environment it operates in.
Runaways wrote: » https://twitter.com/boucherhayes/status/1244897603822800901?s=21https://twitter.com/shanebeattynews/status/1244901322064834560?s=21
Ballso wrote: » But he's done research?
Sultan_of_Ping wrote: » I know the crowd I'm doing some work for at the moment isn't stepping up - mostly because we haven't got a f&*king clue how to make reagents or test kits or ventilators or PCR readers..... ......I expect someone in head office will be getting a letter from SF describing their outrage, and calling on us to step-up The objective we're working to at the moment is keep as many of our workforce as healthy for as long as possible so those suffering non-Covid-19 related ill health can still get the tretments they need.
Sultan_of_Ping wrote: » So gloss over my post and just skip past the inconvenient one that you couldn't answer? This one.... Let me ask you a simpler question then seen as you are not (or cannot) answer the above..... .....if a pharma facility can produce Covid-19 relevant material should it? Should it cease routine production and go fully on to Covid-19 products? And what is your opinion of the opportunity costs involved? Should people suffering from other health conditions just suck-iti-up until Covid-19 has been better controlled?
Sultan_of_Ping wrote: » I know the crowd I'm doing some work for at the moment isn't stepping up........
Runaways wrote: » It was Leo’s idea. It got quite a bit of coverage. You don’t remember?
Augeo wrote: » I'm sure they are stepping up. Keeping the doors open and manufacturing anything that deemed essential in these times is stepping up. I'm at work myself and we are working on a drug that treats a rare condition, we'd all sooner be working from home etc etc etc but that option isn't an option for many.
markodaly wrote: » No, as it was two years ago that it was reported and at that there is no proof that there are bots paid for by FG. So in other words you have no proof that there are paid FG bots out there.
Ballso wrote: » Sure why don't you just ask Sinn Fein supporters in the internet how to produce the drug, they'll surely know
FrancieBrady wrote: » Last night there was NO Capacity in the industry. Read what posters were saying and production could not be easily switched. This AM we see that there is capacity...with a company 'waiting' for contracts to be signed to step up production and another one 'switching production'. Are there more? Who knows unless someone (maybe a 'politician'?) asks and keeps asking the questions. Which is kinda the job of an opposition spokesperson for a particular department, EVEN if it might embarrass/discomfort/or remind your party.
Runaways wrote: » I do. Loads of it. *Gestures broadly at this very thread*
Sultan_of_Ping wrote: » It would be so much better if they asked informed questions rather than just grandstanding and playing to the circle. If a facility is producing a volume (V) of Reagent X and has spare capacity it can easily ramp up production. If it needs to generate additional capacity it can do so in the short-term by postponing maintenance, working overtime, deferring other QA related activities - that gives you a short-run burt but sooner or later kit needs servicing, people get tired and processes need to be checked, validated, verified. A greater capacity can be generated if there are spare hours enough to allow additional shifts - takes a bit longer to grow the workforce but its do-able but equipment still needs downtime Procuring extra kit, extending facilities, commissioning etc takes months (but usually years) so sooner or later you reach the limits of what's possible with what you have in the time allowed. If a facility is producing Reagent Y and you want to swap over to Reagent X, you can't just flip a switch or change the inputs and expect Reagent X to come gushing out in the quantities and qualities desired - it takes time, but yes we could take the SF approach and just give it a lash anyway - sure what could go wrong?
Penfailed wrote: » Are you serious?! You don't think an all island approach makes more sense than for the north to blindly follow Boris Johnston's lead? Virus' don't respect borders y'know.
![Photo of [Deleted User]](https://wc.vanillicon.com/v2/c6e76a2e0d85c3808d93c2f75a0c528d.svg)
